Carmoterol
- Level
- Commodity
- Parent
- 51161500
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51161519This classification denotes an antiasthmatic drug with the molecular formula C21H24N2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9810NUL4D1, chemically known as 8-hydroxy-5-[(1R)-1-hydroxy-2-[[(2R)-1-(4-methoxyphenyl)propan-2-yl]amino]ethyl]-1H-quinolin-2-one but generally known as carmoterol, which bears US NIH Compound Identifier 63952. European Medicines Agency schedules Aarmoterol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB25400. The term CARMOTEROL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19, No. 1, 2005, List 53.). Most nations schedule carmoterol under HS 29337900 and SITC 51561. As of Q4 2014, CARMOTEROL remains the US FDA Preferred Term for this commodity. SMILES: CC(CC1=CC=C(C=C1)OC)NCC(C2=C3C=CC(=O)NC3=C(C=C2)O)O.
Same parent
Under 51161500 · 56Activities that produce or sell this
KBLI · 9Inherited from family 51160000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.